ID

22872

Descrizione

FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH); ODM derived from: https://clinicaltrials.gov/show/NCT00325442

collegamento

https://clinicaltrials.gov/show/NCT00325442

Keywords

versioni (1)
  1. 13/06/17 13/06/17 -
Caricato su

13 giugno 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Pulmonary Hypertension NCT00325442

Inglese

Eligibility Pulmonary Hypertension NCT00325442

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
between 12 and 70 years of age, inclusive.
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
body weight at least 45 kg (approximately 100 pounds).
Descrizione

Body Weight

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0005910
pah that is either idiopathic/heritable (including pah associated with appetite suppressant/toxin use); pah associated with repaired congenital systemic-to-pulmonary shunts (repaired ≥ 5 years); pah associated with collagen vascular disease; or pah associated with hiv.
Descrizione

Idiopathic pulmonary arterial hypertension | Familial primary pulmonary hypertension | Pulmonary arterial hypertension Associated with Appetite Depressants | Pulmonary arterial hypertension Associated with Toxin | Pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunt | Pulmonary arterial hypertension Associated with Collagen Disease | Pulmonary arterial hypertension Associated with HIV Infection

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3203102
UMLS CUI [2]
C0340543
UMLS CUI [3,1]
C2973725
UMLS CUI [3,2]
C0332281
UMLS CUI [3,3]
C0003620
UMLS CUI [4,1]
C2973725
UMLS CUI [4,2]
C0332281
UMLS CUI [4,3]
C0040549
UMLS CUI [5]
C3698160
UMLS CUI [6,1]
C2973725
UMLS CUI [6,2]
C0332281
UMLS CUI [6,3]
C0009326
UMLS CUI [7,1]
C2973725
UMLS CUI [7,2]
C0332281
UMLS CUI [7,3]
C0019693
baseline 6-minute walk distance between 150 and 450 meters, inclusive.
Descrizione

6-minute walk test Distance

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0430515
UMLS CUI [1,2]
C0012751
currently receiving an approved endothelin receptor antagonist and/or an approved phosphodiesterase-5 inhibitor for at least 90 days and on a stable dose for at least the last 30 days.
Descrizione

Endothelin receptor antagonist Dose Stable | Phosphodiesterase 5 inhibitor Dose Stable

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1134681
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2,1]
C1318700
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
previous testing (e.g., right heart catheterization, echocardiography) consistent with the diagnosis of pah.
Descrizione

Catheterization of right heart Consistent with Pulmonary arterial hypertension | Echocardiography Consistent with Pulmonary arterial hypertension

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0189896
UMLS CUI [1,2]
C0332290
UMLS CUI [1,3]
C2973725
UMLS CUI [2,1]
C0013516
UMLS CUI [2,2]
C0332290
UMLS CUI [2,3]
C2973725
reliable and cooperative with protocol requirements.
Descrizione

Protocol Compliance

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0525058
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
nursing or pregnant.
Descrizione

Breast Feeding | Pregnancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006147
UMLS CUI [2]
C0032961
received a prostacyclin within the past 30 days.
Descrizione

Epoprostenol

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0033567
pah due to conditions other than noted in the above inclusion criteria.
Descrizione

Pulmonary arterial hypertension Due to Other medical condition

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2973725
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C3843040
history of uncontrolled sleep apnea, renal insufficiency, anemia, left sided heart disease, uncontrolled systemic hypertension, or parenchymal lung disease.
Descrizione

Sleep Apnea Uncontrolled | Renal Insufficiency | Anemia | Heart Disease Left sided | Uncontrolled hypertension Systemic | Parenchymal lung disorders

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0037315
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C1565489
UMLS CUI [3]
C0002871
UMLS CUI [4,1]
C0018799
UMLS CUI [4,2]
C0443246
UMLS CUI [5,1]
C1868885
UMLS CUI [5,2]
C0205373
UMLS CUI [6]
C0852114
use of an investigational drug within 30 days of baseline.
Descrizione

Investigational New Drugs

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013230
Ritorna all'inizio della pagina

Similar models

Eligibility Pulmonary Hypertension NCT00325442

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
between 12 and 70 years of age, inclusive.
boolean
C0001779 (UMLS CUI [1])
Body Weight
Item
body weight at least 45 kg (approximately 100 pounds).
boolean
C0005910 (UMLS CUI [1])
Idiopathic pulmonary arterial hypertension | Familial primary pulmonary hypertension | Pulmonary arterial hypertension Associated with Appetite Depressants | Pulmonary arterial hypertension Associated with Toxin | Pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunt | Pulmonary arterial hypertension Associated with Collagen Disease | Pulmonary arterial hypertension Associated with HIV Infection
Item
pah that is either idiopathic/heritable (including pah associated with appetite suppressant/toxin use); pah associated with repaired congenital systemic-to-pulmonary shunts (repaired ≥ 5 years); pah associated with collagen vascular disease; or pah associated with hiv.
boolean
C3203102 (UMLS CUI [1])
C0340543 (UMLS CUI [2])
C2973725 (UMLS CUI [3,1])
C0332281 (UMLS CUI [3,2])
C0003620 (UMLS CUI [3,3])
C2973725 (UMLS CUI [4,1])
C0332281 (UMLS CUI [4,2])
C0040549 (UMLS CUI [4,3])
C3698160 (UMLS CUI [5])
C2973725 (UMLS CUI [6,1])
C0332281 (UMLS CUI [6,2])
C0009326 (UMLS CUI [6,3])
C2973725 (UMLS CUI [7,1])
C0332281 (UMLS CUI [7,2])
C0019693 (UMLS CUI [7,3])
6-minute walk test Distance
Item
baseline 6-minute walk distance between 150 and 450 meters, inclusive.
boolean
C0430515 (UMLS CUI [1,1])
C0012751 (UMLS CUI [1,2])
Endothelin receptor antagonist Dose Stable | Phosphodiesterase 5 inhibitor Dose Stable
Item
currently receiving an approved endothelin receptor antagonist and/or an approved phosphodiesterase-5 inhibitor for at least 90 days and on a stable dose for at least the last 30 days.
boolean
C1134681 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C1318700 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Catheterization of right heart Consistent with Pulmonary arterial hypertension | Echocardiography Consistent with Pulmonary arterial hypertension
Item
previous testing (e.g., right heart catheterization, echocardiography) consistent with the diagnosis of pah.
boolean
C0189896 (UMLS CUI [1,1])
C0332290 (UMLS CUI [1,2])
C2973725 (UMLS CUI [1,3])
C0013516 (UMLS CUI [2,1])
C0332290 (UMLS CUI [2,2])
C2973725 (UMLS CUI [2,3])
Protocol Compliance
Item
reliable and cooperative with protocol requirements.
boolean
C0525058 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Breast Feeding | Pregnancy
Item
nursing or pregnant.
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
Epoprostenol
Item
received a prostacyclin within the past 30 days.
boolean
C0033567 (UMLS CUI [1])
Pulmonary arterial hypertension Due to Other medical condition
Item
pah due to conditions other than noted in the above inclusion criteria.
boolean
C2973725 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C3843040 (UMLS CUI [1,3])
Sleep Apnea Uncontrolled | Renal Insufficiency | Anemia | Heart Disease Left sided | Uncontrolled hypertension Systemic | Parenchymal lung disorders
Item
history of uncontrolled sleep apnea, renal insufficiency, anemia, left sided heart disease, uncontrolled systemic hypertension, or parenchymal lung disease.
boolean
C0037315 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C1565489 (UMLS CUI [2])
C0002871 (UMLS CUI [3])
C0018799 (UMLS CUI [4,1])
C0443246 (UMLS CUI [4,2])
C1868885 (UMLS CUI [5,1])
C0205373 (UMLS CUI [5,2])
C0852114 (UMLS CUI [6])
Investigational New Drugs
Item
use of an investigational drug within 30 days of baseline.
boolean
C0013230 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial